347 related articles for article (PubMed ID: 24570384)
1. Interstitial lung disease in patients with rheumatoid arthritis: spontaneous and drug induced.
Hallowell RW; Horton MR
Drugs; 2014 Mar; 74(4):443-50. PubMed ID: 24570384
[TBL] [Abstract][Full Text] [Related]
2. Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
Atzeni F; Boiardi L; Sallì S; Benucci M; Sarzi-Puttini P
Expert Rev Clin Immunol; 2013 Jul; 9(7):649-57. PubMed ID: 23899235
[TBL] [Abstract][Full Text] [Related]
3. Interstitial lung disease related to rheumatoid arthritis: evolution after treatment.
Rojas-Serrano J; González-Velásquez E; Mejía M; Sánchez-Rodríguez A; Carrillo G
Reumatol Clin; 2012; 8(2):68-71. PubMed ID: 22341526
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review.
Roubille C; Haraoui B
Semin Arthritis Rheum; 2014 Apr; 43(5):613-26. PubMed ID: 24231065
[TBL] [Abstract][Full Text] [Related]
6. Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Real-World, Multisite Study of the Impact of Immunosuppression on Pulmonary Function Trajectory.
Matson SM; Baqir M; Moua T; Marll M; Kent J; Iannazzo NS; Boente RD; Donatelli JM; Dai J; Diaz FJ; Demoruelle MK; Hamblin MB; Mathai SK; Ryu JH; Pope K; Walker CM; Lee JS
Chest; 2023 Apr; 163(4):861-869. PubMed ID: 36470416
[TBL] [Abstract][Full Text] [Related]
7. Potential Rheumatoid Arthritis-Associated Interstitial Lung Disease Treatment and Computational Approach for Future Drug Development.
Jeong E; Hong H; Lee YA; Kim KS
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473928
[TBL] [Abstract][Full Text] [Related]
8. Overview of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Its Treatment.
Pugashetti JV; Lee JS
Semin Respir Crit Care Med; 2024 Jun; 45(3):329-341. PubMed ID: 38484788
[TBL] [Abstract][Full Text] [Related]
9. Management issues in rheumatoid arthritis-associated interstitial lung disease.
England BR; Hershberger D
Curr Opin Rheumatol; 2020 May; 32(3):255-263. PubMed ID: 32141954
[TBL] [Abstract][Full Text] [Related]
10. Evolution of imaging findings, laboratory and functional parameters in rheumatoid arthritis patients after one year of treatment with anti-TNF-α agents.
Detorakis EE; Magkanas E; Lasithiotaki I; Sidiropoulos P; Boumpas DT; Gourtsoyiannis N; Antoniou K; Raissaki M
Clin Exp Rheumatol; 2017; 35(1):43-52. PubMed ID: 27908307
[TBL] [Abstract][Full Text] [Related]
11. Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent.
Koo BS; Hong S; Kim YJ; Kim YG; Lee CK; Yoo B
Korean J Intern Med; 2015 Jan; 30(1):104-9. PubMed ID: 25589842
[TBL] [Abstract][Full Text] [Related]
12. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts.
Kiely P; Busby AD; Nikiphorou E; Sullivan K; Walsh DA; Creamer P; Dixey J; Young A
BMJ Open; 2019 May; 9(5):e028466. PubMed ID: 31061059
[TBL] [Abstract][Full Text] [Related]
13. Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
Kurata I; Tsuboi H; Terasaki M; Shimizu M; Toko H; Honda F; Ohyama A; Yagishita M; Osada A; Ebe H; Kawaguchi H; Takahashi H; Hagiwara S; Asashima H; Kondo Y; Matsumoto I; Sumida T
Intern Med; 2019 Jun; 58(12):1703-1712. PubMed ID: 30799358
[TBL] [Abstract][Full Text] [Related]
14. Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies.
Chen J; Chi S; Li F; Yang J; Cho WC; Liu X
Expert Opin Biol Ther; 2017 Mar; 17(3):265-283. PubMed ID: 28117616
[TBL] [Abstract][Full Text] [Related]
15. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients.
Fernández-Díaz C; Castañeda S; Melero-González RB; Ortiz-Sanjuán F; Juan-Mas A; Carrasco-Cubero C; Casafont-Solé I; Olivé A; Rodríguez-Muguruza S; Almodóvar-González R; Castellanos-Moreira R; Rodríguez-García SC; Aguilera-Cros C; Villa I; Ordóñez-Palau S; Raya-Alvarez E; Morales-Garrido P; Ojeda-García C; Moreno-Ramos MJ; Bonilla Hernán MG; Hernández Rodríguez I; López-Corbeto M; Andreu JL; Jiménez de Aberásturi JRD; Ruibal-Escribano A; Expósito-Molinero R; Pérez-Sandoval T; López-Robles AM; Carreira-Delgado P; Mena-Vázquez N; Urruticoechea-Arana A; Peralta-Ginés C; Arboleya-Rodríguez L; Narváez García FJ; Palma-Sánchez D; Cervantes Pérez EC; Maiz-Alonso O; Alvarez-Rivas MN; Fernández-Melón J; Vela Casasempere P; Cabezas-Rodríguez I; Castellvi-Barranco I; González-Montagut C; Blanco-Madrigal J; Del Val-Del Amo N; Fito MC; Rodríguez-Gómez M; Salgado-Pérez E; García-Magallón B; Hidalgo-Calleja C; López-Sánchez R; Fernández-Aguado S; Fernández-López JC; Castro-Oreiro S; Serrano-García I; García-Valle A; Romero-Yuste S; Expósito-Pérez L; Pérez-Albadalejo L; García-Aparicio A; Quillis-Marti N; Bernal-Vidal JA; Loricera-García J; Hernández JL; González-Gay MA; Blanco R
Rheumatology (Oxford); 2020 Dec; 59(12):3906-3916. PubMed ID: 33068439
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis related interstitial lung disease - improving outcomes over 25 years: a large multicentre UK study.
Kelly CA; Nisar M; Arthanari S; Carty S; Woodhead FA; Price-Forbes A; Middleton D; Dempsey O; Miller D; Basu N; Dawson J; Sathi N; Ahmad Y; Palmer E; Iqbal K; Janakiraman G; Koduri G; Young A
Rheumatology (Oxford); 2021 Apr; 60(4):1882-1890. PubMed ID: 33150434
[TBL] [Abstract][Full Text] [Related]
18. Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study.
Akiyama M; Kaneko Y; Yamaoka K; Kondo H; Takeuchi T
Rheumatol Int; 2016 Jun; 36(6):881-9. PubMed ID: 27072347
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease.
Akiyama M; Kaneko Y
Autoimmun Rev; 2022 May; 21(5):103056. PubMed ID: 35121155
[TBL] [Abstract][Full Text] [Related]
20. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.
Wu EK; Ambrosini RD; Kottmann RM; Ritchlin CT; Schwarz EM; Rahimi H
Curr Rheumatol Rev; 2019; 15(4):277-289. PubMed ID: 30652645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
